Ceftriaxone Injection manufacturers & suppliers

Ceftriaxone Injection

Form: Lyophilized powder/ Prefilled syringe

Strength: 250 mg, 1 g, and 2 g

Reference Brands: Rocephin

Category: Active Pharmaceutical Ingredient

Ceftriaxone injectable API is regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP standards. In the US, FDA approval involves clinical validation, safety assessments, and GMP compliance, while in the EU, CE marking certifies conformity with MDR standards. These APIs undergo validation, stability testing, and audits, with comprehensive documentation including safety profiles, clinical data, and manufacturing practices. For licensing procedures, approved dossiers, and latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to high-quality ceftriaxone APIs vital for treating systemic bacterial infections worldwide, supporting effective antimicrobial therapy and patient care.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Zinc Sulfate Powder

Strength: Typically supplied as high-purity powder or crystals

Form: Powder/Granules or lumps

Reference Brands: Generic zinc sulfate

View Details
Clotrimazole Granules Or Pastes

Strength: High-purity API

Form: Granules/ Paste

Reference Brands: Generic clotrimazole APIs

View Details
Clotrimazole Granules Or Pastes

Strength: High-purity API

Form: Granules/ Paste

Reference Brands: Generic clotrimazole APIs

View Details
Mupirocin Granules

Strength: Pharmaceutical-grade powders for formulation into topical creams, ointments, or injectable products

Form: Granules/powder

Reference Brands: Generic mupirocin API

View Details

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.